MAOA is overexpressed in the transition from breast cancer bone metastatic dormancy to relapse (Lu et al, 2011) and is required for breast tumor‐initiating cells (Gwynne et al, 2019) and promotes prostate cancer metastasis (Wu et al, 2017). Here, MAOA is linked to prostate cancer.